Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2100622	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	License Renew	2021-09-16		Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHZ2100621	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	License Renew	2021-09-16		Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHB2400518	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2024-10-01		Novartis Pharma Schweiz AG			view
JYHB2200188	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2022-04-08		Novartis Pharma Schweiz AG			view
JYHB2200187	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2022-04-08		Novartis Pharma Schweiz AG			view
JYHB2101244	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-07-09		Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHB2101243	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-07-09		Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHB2101057	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-04-23		Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHB2101056	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-04-23		Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG			view
JYHB2100035	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-01-12	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	In Review	2021-01-11	view
JYHB2100034	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2021-01-12	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	In Review	2021-01-11	view
JYHB2002599	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-12-18	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-12-25	view
JYHB2002598	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-12-18	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-12-25	view
JYHB2000900	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-06-19	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-06-22	view
JYHB2000899	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-06-19	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-06-22	view
JYHB2000517	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-05-10	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2020-11-20	view
JYHB2000516	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-05-10	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Certificate Issued	2020-11-20	view
JYHB2000315	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-03-25	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-04-10	view
JYHB2000314	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2020-03-25	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-04-10	view
JYHB1901586	培唑帕尼片	pazopanib	Tablet	Chemical Drugs	Supplementary Application	2019-12-23	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG	Filed	2020-01-03	view